Dr Lal PathLabs launch advanced test for Amyloidosis
Samples can be collected from anywhere in India and sent to the National Reference Lab, Rohini, New Delhi, for testing
Dr Lal PathLabs has introduced Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry – a test for accurately identifying different types of Amyloid proteins. With this launch, DLPL becomes the first diagnostic chain in South Asia to offer this specialised test.
Amyloidosis is a disease where the abnormal or misfolded amyloid protein accumulates in various vital organs, leading to loss of function or even death in some cases. More than 40 types of Amyloid proteins have been discovered to date, and precise knowledge about the type of Amyloid helps doctors in choosing the correct treatment or management plan for the patient. Kidney, heart, lungs, and skin are the most common involved, however, any organ in the body can be affected.
Key Highlights:
- Nationwide availability – Samples can be collected from anywhere in India and sent to National Reference Lab, Rohini, New Delhi, for testing.
- Accurate diagnosis – Helps doctors determine the specific type of Amyloid, enabling targeted treatment and better outcomes.
- Access for hospitals – All hospitals can facilitate sample collection for patients and send to Dr Lal PathLabs for testing.
Dr. Lal PathLabs has launched this test under the guidance of the National Amyloidosis Centre, London (UK).
- Advertisement -